Drugs / Picoplatin

Trials 8 · a red edge is where a trial was stopped

200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 13 trials
Phase 1 NCT00710697 Jun 2008 → Mar 2009 cancer Poniard Pharmaceuticals Unknown No outcome recorded
Phase 1 NCT00465725 Apr 2007 → Jul 2009 breast cancer, colorectal cancer, head and neck cancer, lung cancer +4 Poniard Pharmaceuticals Completed No outcome recorded
Phase 1 NCT00016172 Nov 2000 → Apr 2002 lymphoma, small intestine cancer Memorial Sloan Kettering Cancer Center Completed No outcome recorded
Phase 1/22 trials
Phase 1/2 NCT00448734 Jun 2006 → Dec 2009 hormone-resistant prostate carcinoma Poniard Pharmaceuticals Unknown No outcome recorded
Phase 1/2 NCT00478946 Apr 2006 → Dec 2009 colorectal cancer Poniard Pharmaceuticals Unknown No outcome recorded
Phase 22 trials
Phase 2 NCT00116610 Jun 2005 → Mar 2007 small cell lung carcinoma Poniard Pharmaceuticals Completed No outcome recorded
Phase 2 NCT00021008 lung cancer Jonsson Comprehensive Cancer Center Unknown No outcome recorded
Phase 31 trial
Phase 3 NCT00465491 Apr 2007 → May 2009 small cell lung carcinoma Poniard Pharmaceuticals Unknown No outcome recorded

Evidence & citations 8 cited values

Every value below carries the sentence it was read from. 9 sources stand behind the page.

FieldValueCited text
Known as picoplatin ClinicalTrials.gov intervention name — accepted as the source's own label NCT00465491
7

NCT00021008

NCT00016172

NCT00116610

NCT00710697

NCT00448734

NCT00478946

NCT00465725

Known as AMD473 “Results from preclinical studies indicate that picoplatin (previously called AMD473 or ZD0473) may be able to overcome or partially overcome platinum resistance.” NCT00116610
Known as NX 473 ChEMBL registry synonym — accepted as the source's own label CHEMBL3544907
Known as Picoplatine ChEMBL registry synonym — accepted as the source's own label CHEMBL3544907
Known as Picoplatino ChEMBL registry synonym — accepted as the source's own label CHEMBL3544907
Known as ZD0473 “Results from preclinical studies indicate that picoplatin (previously called AMD473 or ZD0473) may be able to overcome or partially overcome platinum resistance.” NCT00116610
Modality Small molecule CHEMBL3544907
Route Intravenous “Docetaxel will be given intravenously over 60 minutes, followed 30 minutes later by picoplatin as a 1-2 hour intravenous infusion.” NCT00448734